La vendita allo scoperto per ProMIS Neurosciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di ProMIS Neurosciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

ProMIS Neurosciences (NASDAQ:PMN) Azioni, Report sulle vendite allo scoperto

ProMIS Neurosciences

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

RBC Capital analyst Sabahat Khan maintains AutoCanada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ACQ#TSX">ACQ</a>) with a Sector Perform and raises the price target from C$18 to C$27.

News

Price Target

Analyst Ratings

TSX:ACQ

RBC Capital Maintains Sector Perform on AutoCanada, Raises Price Target to C$27

KLTO

Klotho Neurosciences Partners With AAVnerGene To Manufacture Gene Therapy Assets

Truist Securities analyst David Smith maintains F N B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>) with a Buy and raises the price target from $17.5 to $18.

Truist Securities Maintains Buy on F N B, Raises Price Target to $18

U.S. stocks were mixed, with the Nasdaq Composite falling around 100 points on Tuesday.
Shares of D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) rose sharply during Monday's session after the company announced <a href="https://www.benzinga.com/quote/DHI/earnings">upbeat quarterly results.</a>
D.R. Horton reported fiscal third-quarter revenue of $9.22 billion, beating analyst estimates of $8.79 billion, according to Benzinga Pro. The U.S. homebuilder reported third-quarter earnings of $3.36 per share, beating analyst estimates of $2.92 per share.
D.R. Horton shares climbed 12.5% to $147.66 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) shares jumped 56.7% to $484.50 after the company reported strong financial results for the second quarter and raised its full-year guidance.</li>
<li>Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) gained 24.6% to $12.98 amid mentions of the stock on social media.</li>
<li>Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) climbed 22.7% to $5.72.</li>
<li>Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) jumped 21.3% to $19.95 after the company announced it has secured new Sonoma system orders.</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) gained 17.4% to $186.73 following upbeat quarterly earnings.</li>
<li>Stoke Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) rose 16.1% to $14.30.</li>
<li>ICON Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) jumped 15.4% to $161.13.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) gained 15% to $2.87.</li>
<li>Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) climbed 12.9% to $4.5500.</li>
<li>Uranium Royalty Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UROY#NASDAQ">UROY</a>) rose 12.6% to $3.02.</li>
<li>Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLRS#NYSE">VLRS</a>) rose 12.4% to $4.96.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 12% to $3.6298.</li>
<li>Alpha Metallurgical Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMR#NYSE">AMR</a>) shares rose 11.3% to $140.42. Alpha will announce second quarter financial results on Aug. 8.</li>
<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) gained 11% to $17.66.</li>
<li>Charles River Laboratories International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) rose 10.3% to $165.29.</li>
<li>Core Natural Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) gained 9.6% to $84.76. Core Natural Resources will announce second quarter results on Aug. 5.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) gained 9% to $14.12.</li>
<li>Warrior Met Coal, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCC#NYSE">HCC</a>) rose 8% to $58.74. Warrior Met Coal will hold its second quarter 2025 investor conference call on Wednesday, Aug. 6.</li>
<li>Northrop Grumman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) gained 7.8% to $555.74 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) rose 6.4% to $207.05.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46541551/how-to-earn-500-a-month-from-att-stock-ahead-of-q2-earnings">How To Earn $500 A Month From AT&amp;T Stock Ahead Of Q2 Earnings</a></li>
</ul>
Photo via Shutterstock

AEHR

FTRE

ICLR

IOVA

MEDP

PONY

STOK

UROY

VLRS

WOOF

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday

RBC Capital analyst Jon Arfstrom maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Sector Perform and raises the price target from $57 to $62.

ZION

RBC Capital Maintains Sector Perform on Zions Bancorp, Raises Price Target to $62

DA Davidson analyst Kurt Yinger maintains Weyerhaeuser (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) with a Buy and lowers the price target from $36 to $35.

DA Davidson Maintains Buy on Weyerhaeuser, Lowers Price Target to $35

RBC Capital analyst Jonathan Atkin maintains Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) with a Sector Perform and raises the price target from $45 to $46.

RBC Capital Maintains Sector Perform on Verizon Communications, Raises Price Target to $46

DA Davidson analyst Michael Shlisky downgrades Alamo Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALG#NYSE">ALG</a>) from Buy to Neutral and announces $225 price target.

Downgrades

DA Davidson Downgrades Alamo Group to Neutral, Announces $225 Price Target

<a href="https://www.bloomberg.com/news/articles/2025-07-22/microsoft-says-chinese-hackers-exploiting-sharepoint-flaws?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-22/microsoft-says-chinese-hackers-exploiting-sharepoint-flaws?embedded-checkout=true</a>

General

MSFT

'Microsoft Says Chinese Hackers Exploiting SharePoint Flaws'- Bloomberg

Truist Securities analyst Matthew Coad maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $58 to $72.

AFRM

Truist Securities Maintains Buy on Affirm Holdings, Raises Price Target to $72

LanzaTech Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) ("LanzaTech" or the "Company") a leader in carbon management solutions, announced it has received a grant of £6.4 million from the UK government's Advanced Fuels Fund (AFF), operated by the Department for Transport (DfT).
The grant will accelerate the development of LanzaTech's innovative DRAGON 1 &amp; 2 projects, each playing a crucial role in the production of sustainable aviation fuel (SAF) in the UK. Project DRAGON stands for&nbsp;Decarbonizing and&nbsp;Reimagining&nbsp;Aviation for the&nbsp;Goal&nbsp;Of&nbsp;Netzero.
The DRAGON 1 project is LanzaTech's existing UK SAF project that will convert recycled carbon fuel ethanol (including ethanol from LanzaTech's gas fermentation process) into Advanced SAF in Port Talbot, South Wales, using the LanzaJet&#xAE; Alcohol-to-Jet (AtJ) process.
The DRAGON 2 project is a Power-to-Liquid (PtL) facility that will convert waste carbon dioxide and green hydrogen into ethanol for subsequent conversion into PtL SAF at an adjacent facility using the LanzaJet&#xAE; Alcohol-to-Jet (AtJ) process. The location for DRAGON 2 in the UK will be determined during this grant-funded project.

LNZA

LanzaTech Global Receives Grant Of £6.4M From UK Government's AFF To Accelerate Development Of DRAGON 1 & 2 Projects

MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) announced its fiscal 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46539445/msci-reports-financial-results-for-second-quarter-and-six-months-2025" rel="noreferrer noopener">second-quarter results</a> on Tuesday. The company&#8217;s total revenue reached $772.7 million, an increase of 9.1% year-over-year, exceeding the analyst consensus estimate of $763.5 million. Adjusted earnings per share (EPS) were $4.17, also surpassing the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus</a> of $4.11.
As of June 30, 2025, MSCI&#8217;s total run rate, the annualized value of recurring revenues, grew by 10.7% year-over-year to $3.11 billion. The organic recurring subscription run rate saw a 7.4% increase. The client retention rate was 94.4%, a slight decrease from 94.8% in the previous year.
<h2 class="wp-block-heading">Segment Performance</h2>
MSCI&#8217;s Index operating revenues increased 9.5% year-over-year to $434.8 million, driven by higher recurring subscription revenues and asset-based fees.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/44926167/msci-builds-momentum-with-q1-beat-confidence-in-long-term-demand" rel="noreferrer noopener">MSCI Builds Momentum With Q1 Beat, Confidence In Long-Term Demand</a>
Analytics operating revenues rose 7.1% year-over-year to $177.7 million, primarily due to increased recurring subscription revenues from equity and multi-asset class analytics products.
Sustainability and climate operating revenues (formerly ESG and climate operating revenues) grew 11.3% year-over-year to $88.9 million, supported by growth in ratings and climate products. Finally, All Other – private assets operating revenues improved by 9.7% year-over-year to $71.2 million.
<h2 class="wp-block-heading">Margins, Cash Flow, and Capital Allocation</h2>
The operating margin improved from 54.0% to 55.0%, and the adjusted EBITDA margin increased from 60.7% to 61.4%.
MSCI generated $301.6 million in free cash flow during the quarter and held $347.3 million in cash and equivalents as of June 30, 2025.
The company invested $34.6 million in capital expenditures. MSCI returned capital to shareholders through $131.2 million in share repurchases, buying back 250,818 shares at an average price of $523.20. Additionally, approximately $139.3 million was paid in dividends.
On July 21, the Board declared a third-quarter cash dividend of $1.80 per share, payable August 29 to shareholders of record as of August 15, 2025.
<h2 class="wp-block-heading">CEO Commentary and Outlook</h2>
Chair and CEO Henry A. Fernandez noted MSCI delivered strong financial results for the quarter, driven by 17% growth in asset-based fee (ABF) run rate, supported by record AUM in ETFs linked to its indexes. The company led all index providers in equity ETF cash inflows and achieved double-digit subscription run-rate growth across key client segments, including banks, broker-dealers, wealth managers, hedge funds, and asset owners, while maintaining steady growth and high retention among asset managers.
MSCI also expanded its existing solutions to meet a broader range of client use cases and continued developing new offerings for a more diverse client base. The company leveraged its resilient financial model and integrated products to deliver scalable, innovative solutions that help clients advance their strategies.
FY25 Outlook
MSCI <a href="https://www.benzinga.com/news/earnings/25/04/44926167/msci-builds-momentum-with-q1-beat-confidence-in-long-term-demand" target="_blank" rel="noreferrer noopener">reiterated operating expenses</a> of $1.405 billion-$1.445 billion, capex of $115-$125 million, and free cash flow of $1.40 billion-$1.46 billion.
Price Action: MSCI stock is trading lower by 3.46% to $557.95 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46541517/elon-musk-says-they-simply-dont-have-the-funding-doubts-stargate-ai" target="_blank" rel="noreferrer noopener">Elon Musk Says &#8216;They Simply Don&#8217;t&#8217; Have The Funding, Doubts Stargate AI</a></li>
</ul>
Photo via Shutterstock

Earnings

Guidance

Movers

MSCI

MSCI's Q2 Success Fueled By Record ETF Growth, Diverse Client Expansion

Dan Schweber was enrolled in Columbia University's executive MBA program back in 2019. Disillusioned with corporate life and not in a financial position to launch his own company, Schweber was uncertain what his future would look like.
Until he caught wind of a week-long elective intensive that focused on search funds. These funds, he learned, provided a path into small business entrepreneurship through the acquisition of already-established companies.
By the end of the first day of the course, Schweber was hooked. "I couldn&#8217;t believe it,&#8221; he told <a href="https://www.businessinsider.com/the-elite-mbas-ditching-corporate-america-2025-7">Business Insider</a>. &#8220;I was like, I can do this.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to grab <a href="https://www.benzinga.com/money/mode-mobile-2">4,000 of its pre-IPO shares for just $0.30/share</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Today, Schweber, who is the CEO of an Atlanta-based 60-person air duct cleaning company, is one of a growing number of search fund entrepreneurs.
Search funds provide a unique pathway to a corner office. They work like this— instead of raising capital to build a product or prove an idea, entrepreneurs will use that money to buy an already established, successful business and then install themselves as the new owner/CEO.&nbsp;
The country is chock-full of businesses that meet this criteria, many of which are owned by Boomers looking to retire, making it a win-win situation for both parties. The catch, Business Insider reports, is that many of these opportunities are in the less-exciting corners of the economy, like plumbing, dumpster rentals, and pool construction.
The concept is not new. Business Insider reports that it dates back to the 1980s, but really took off in the post-pandemic years as dreams of climbing the corporate ladder began to look less appealing.
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
For many, like Schweber, the decision to opt out of the rat race and into small business ownership is a life-changing one.&nbsp;
"It&#8217;s just the best," he told Business Insider. "I will never work in a corporate job ever again. There&#8217;s no amount of money that you could give me.&#8221;
However, Schweber warns that it isn't necessarily an easy route, nor is it something that can happen overnight.
Typically, it takes a search fund entrepreneur two years and thousands of cold calls to current owners to find the right fit. In the end, about one-third of searchers never end up buying a business, either because they get discouraged by the process or because they're unable to make the right match.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Once a searcher closes the deal and buys a company, the work is only beginning. According to Business Insider, 31% of searchers wind up losing money for their investors, and many more find themselves kicked to the curb after proving themselves unable to hack it as CEO.&nbsp;
Even those who manage to hold on to their position and keep the company afloat may not see any payout when it comes time to sell. Just under 25% of searchers earn no profit when they eventually sell their acquired business, and only 18% earn eight figures.
But for the successful few, like Schweber, the risk and the workload are well worth it.
&#8220;You&#8217;ve got to be all in,&#8221; he told Business Insider. &#8220;If you have the safety of a job, you&#8217;re never going to need it enough. You&#8217;ve got to burn the boats.&#8221;
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

They Skipped Corporate America—And Bought A Company Instead. Meet The New CEO Fast-Track

NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has outperformed the market over the past 15 years by 41.82% on an annualized basis producing an average annual return of 54.06%. Currently, NVIDIA has a market capitalization of $4.04 trillion. 
Buying $100 In NVDA: If an investor had bought $100 of NVDA stock 15 years ago, it would be worth $63,300.19 today based on a price of $165.53 for NVDA at the time of writing.
<h3>NVIDIA's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753193712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

NVDA

$100 Invested In NVIDIA 15 Years Ago Would Be Worth This Much Today

Canaccord Genuity analyst William Plovanic maintains Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) with a Buy and lowers the price target from $97 to $90.

GMED

Canaccord Genuity Maintains Buy on Globus Medical, Lowers Price Target to $90

WIIM

Equifax shares are trading lower after the company reported Q2 financial results and issued Q3 adjusted EPS guidance below estimates.

Reuters Cites Philip Morris International CFO Emmanuel Babeau Saying We Think Vape Brand VEEV Can Have A Similar Level Of Profitability As Cigarettes

Canaccord Genuity analyst Austin Moeller maintains BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) with a Buy and lowers the price target from $28 to $27.

BlackSky Technology Inc. Class A Common Stock

BKSY

Canaccord Genuity Maintains Buy on BlackSky Technology, Lowers Price Target to $27

CRCL

Circle Internet Group shares are trading lower after Compass Point downgraded the stock from Neutral to Sell and lowered its price target from $205 to $130.

OPEN

Opendoor Technologies Shares Resume Trade

Press Releases

ProMIS Neurosciences to Participate in the 37th Annual Roth Conference

ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer's Disease/Parkinson's Disease 2025 International Conference

ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights

ProMIS Neurosciences Announces First Quarter 2025 Financial Results

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson (NYSE: MCK) Sends "FOCUSfactor" Exploding Across North America – More Stocks Inside

ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer's Disease

ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules

ProMIS Neurosciences Announces Private Placement Financing

AMZN

COST

DARE

PNPNF

SNYR

TSXV:PNPN

WOLF

HC Wainwright & Co.

Maxim Group

Guggenheim

BTIG

ProMIS Neurosciences shares are trading lower after the company announced a $0.8 million at-the-market direct offering.

Comments

ProMIS Neurosciences

Vendite allo scoperto

ProMIS Neurosciences (NASDAQ:PMN) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO